Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans.


Journal

Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578

Informations de publication

Date de publication:
Dec 2023
Historique:
accepted: 18 09 2023
medline: 24 11 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Growth hormone receptor knockout (GHR-KO) pigs have recently been developed, which serve as a large animal model of Laron syndrome (LS). GHR-KO pigs, like individuals with LS, are obese but lack some comorbidities of obesity. The purpose of this study was to examine the histological and transcriptomic phenotype of adipose tissue (AT) in GHR-KO pigs and humans with LS. Intraabdominal (IA) and subcutaneous (SubQ) AT was collected from GHR-KO pigs and examined histologically for adipocyte size and collagen content. RNA was isolated and cDNA sequenced, and the results were analyzed to determine differentially expressed genes that were used for enrichment and pathway analysis in pig samples. For comparison, we also performed limited analyses on human AT collected from a single individual with and without LS. GHR-KO pigs have increased adipocyte size, while the LS AT had a trend towards an increase. Transcriptome analysis revealed 55 differentially expressed genes present in both depots of pig GHR-KO AT. Many significant terms in the enrichment analysis of the SubQ depot were associated with metabolism, while in the IA depot, IGF and longevity pathways were negatively enriched. In pathway analysis, multiple expected and novel pathways were significantly affected by genotype, i.e. KO vs. controls. When GH related gene expression was analyzed, SOCS3 and CISH showed species-specific changes. AT of GHR-KO pigs has several similarities to that of humans with LS in terms of adipocyte size and gene expression profile that help describe the depot-specific adipose phenotype of both groups.

Identifiants

pubmed: 37747600
doi: 10.1007/s11102-023-01355-y
pii: 10.1007/s11102-023-01355-y
doi:

Substances chimiques

Receptors, Somatotropin 0
Growth Hormone 9002-72-6
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

660-674

Subventions

Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States
Organisme : NIH HHS
ID : AG059779
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Laron Z, Werner H (2021) Laron syndrome - A historical perspective. Rev Endocr Metab Disord 22(1):31–41
pubmed: 32964395 doi: 10.1007/s11154-020-09595-0
Zhou Y et al (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94(24):13215–13220
pubmed: 9371826 pmcid: 24289 doi: 10.1073/pnas.94.24.13215
Young J et al (2021) Mouse models of growth hormone insensitivity. Rev Endocr Metab Disord 22(1):17–29
pubmed: 33037595 doi: 10.1007/s11154-020-09600-6
Hinrichs A et al (2018) Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver. Mol Metab 11:113–128
pubmed: 29678421 pmcid: 6001387 doi: 10.1016/j.molmet.2018.03.006
Laron Z et al (1992) Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339(8804):1258–1261
pubmed: 1349669 doi: 10.1016/0140-6736(92)91594-X
Laron Z, Klinger B (1993) Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. Horm Res 40(1–3):16–22
pubmed: 8300045 doi: 10.1159/000183762
Laron Z et al (2006) Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol (Oxf) 65(1):114–117
pubmed: 16817829 doi: 10.1111/j.1365-2265.2006.02558.x
Laron Z (2011) In: Kopchick JJ (ed) Laron Syndrome - from man to mouse: Lessons from clinical and experimental experience, 531xiv, p. edn. Springer, Berlin; London
doi: 10.1007/978-3-642-11183-9
Shevah O, Laron Z (2007) Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res 17(1):54–57
pubmed: 17166755 doi: 10.1016/j.ghir.2006.10.007
Steuerman R, Shevah O, Laron Z (2011) Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinol 164(4):485–489
pubmed: 21292919 doi: 10.1530/EJE-10-0859
Guevara-Aguirre J et al (2021) Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador. Rev Endocr Metab Disord 22(1):59–70
pubmed: 33047268 doi: 10.1007/s11154-020-09602-4
Guevara-Aguirre J et al (2023) Cancer in growth hormone excess and growth hormone deficit. Endocr Relat Cancer, 30(10)
Ikeno Y et al (2009) Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci 64(5):522–529
pubmed: 19228785 doi: 10.1093/gerona/glp017
Coschigano KT et al (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141(7):2608–2613
pubmed: 10875265 doi: 10.1210/endo.141.7.7586
Berryman DE et al (2011) Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res 21(3):113–123
pubmed: 21470887 pmcid: 3112270 doi: 10.1016/j.ghir.2011.03.002
Kanety H et al (2009) Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol 161(6):837–844
pubmed: 19755405 doi: 10.1530/EJE-09-0419
Berryman DE, List EO (2017) Growth hormone’s effect on adipose tissue: Quality versus Quantity. Int J Mol Sci, 18(8)
Stout MB et al (2014) Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging 6(7):575–586
pubmed: 25063774 pmcid: 4153624 doi: 10.18632/aging.100681
Young JA et al (2020) GHR(-/-) mice are protected from obesity-related white adipose tissue inflammation. J Neuroendocrinol 32(11):e12854
pubmed: 32350959 pmcid: 7554100 doi: 10.1111/jne.12854
Bennis MT et al (2017) The role of transplanted visceral fat from the long-lived growth hormone receptor knockout mice on insulin signaling. Geroscience 39(1):51–59
pubmed: 28299640 pmcid: 5352587 doi: 10.1007/s11357-017-9957-y
Albl B et al (2016) Tissue Sampling Guides for Porcine Biomedical Models. Toxicol Pathol 44(3):414–420
pubmed: 26883152 doi: 10.1177/0192623316631023
List EO et al (2019) Adipocyte-specific GH receptor-null (AdGHRKO) mice have enhanced insulin sensitivity with reduced liver triglycerides. Endocrinology 160(1):68–80
pubmed: 30462209 doi: 10.1210/en.2018-00850
Tchoukalova YD et al (2010) Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obes (Silver Spring) 18(10):1875–1880
doi: 10.1038/oby.2010.56
Rasband WS (1997–2018) Quantifying Stained Liver Tissue. [cited 2023; Available from: https://imagej.nih.gov/ij/docs/examples/stained-sections/index.html
Dobin A et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15–21
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7):923–930
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Wang L, Wang S, Li W (2012) RSeQC: quality control of RNA-seq experiments. Bioinformatics 28(16):2184–2185
pubmed: 22743226 doi: 10.1093/bioinformatics/bts356
Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140
pubmed: 19910308 doi: 10.1093/bioinformatics/btp616
Ritchie ME et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Wickham H (2016) ggplot2: elegant graphics for data analysis, in Use R! Springer International Publishing, Cham. Imprint: Springer,: p. 1 online resource (XVI, 260 pages 232 illustrations, 140 illustrations in color
doi: 10.1007/978-3-319-24277-4
Chen H, Boutros PC (2011) VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics 12:35
pubmed: 21269502 pmcid: 3041657 doi: 10.1186/1471-2105-12-35
Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32(18):2847–2849
pubmed: 27207943 doi: 10.1093/bioinformatics/btw313
Wu T et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb) 2(3):100141
Berryman DE et al (2004) Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res 14(4):309–318
pubmed: 15231300 doi: 10.1016/j.ghir.2004.02.005
Householder LA et al (2018) Increased fibrosis: a novel means by which GH influences white adipose tissue function. Growth Horm IGF Res 39:45–53
pubmed: 29279183 doi: 10.1016/j.ghir.2017.12.010
List EO et al (2013) The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol 27(3):524–535
pubmed: 23349524 pmcid: 3589669 doi: 10.1210/me.2012-1330
Chaves VE, Junior FM, Bertolini GL (2013) The metabolic effects of growth hormone in adipose tissue. Endocrine 44(2):293–302
pubmed: 23430368 doi: 10.1007/s12020-013-9904-3
Sun K et al (2013) Fibrosis and adipose tissue dysfunction. Cell Metab 18(4):470–477
pubmed: 23954640 pmcid: 3795900 doi: 10.1016/j.cmet.2013.06.016
Troike KM et al (2017) Impact of growth hormone on regulation of adipose tissue. Compr Physiol 7(3):819–840
pubmed: 28640444 doi: 10.1002/cphy.c160027
Hinrichs A et al (2021) MECHANISMS IN ENDOCRINOLOGY: transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models. Eur J Endocrinol 185(2):R35–R47
pubmed: 34048365 doi: 10.1530/EJE-21-0013
Qian Y et al (2022) Mice with gene alterations in the GH and IGF family. Pituitary 25(1):1–51
pubmed: 34797529 doi: 10.1007/s11102-021-01191-y
Ceddia RP et al (2016) The PGE2 EP3 receptor regulates Diet-Induced Adiposity in male mice. Endocrinology 157(1):220–232
pubmed: 26485614 doi: 10.1210/en.2015-1693
Stout MB et al (2015) Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice. Oncotarget 6(29):26702–26715
pubmed: 26436954 pmcid: 4694946 doi: 10.18632/oncotarget.5760
Duran-Ortiz S et al (2020) Differential gene signature in adipose tissue depots of growth hormone transgenic mice. J Neuroendocrinol 32(11):e12893
pubmed: 33043505 pmcid: 7606825 doi: 10.1111/jne.12893
Young JA et al (2021) Transcriptome profiling of insulin sensitive tissues from GH deficient mice following GH treatment. Pituitary 24(3):384–399
pubmed: 33433889 pmcid: 8122029 doi: 10.1007/s11102-020-01118-z
Marmol-Sanchez E et al (2022) Modeling microRNA-driven post-transcriptional regulation using exon-intron split analysis in pigs. Anim Genet 53(5):613–626
pubmed: 35811409 doi: 10.1111/age.13238
Valdes-Hernandez J et al (2023) Global analysis of the association between pig muscle fatty acid composition and gene expression using. RNA-Seq Sci Rep 13(1):535
pubmed: 36631502 doi: 10.1038/s41598-022-27016-x
Riedel EO et al (2020) Functional changes of the liver in the absence of growth hormone (GH) action - proteomic and metabolomic insights from a GH receptor deficient pig model. Mol Metab 36:100978
pubmed: 32277923 pmcid: 7184181 doi: 10.1016/j.molmet.2020.100978
Schilloks MC et al (2023) Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune cells of a Porcine Model for Laron Syndrome. Biomolecules, 13(4)
Aguiar-Oliveira MH, Bartke A (2019) Growth Hormone Deficiency: Health and Longevity Endocr Rev 40(2):575–601
pubmed: 30576428
Nelson CN et al (2018) Growth hormone activated STAT5 is required for induction of beige fat in vivo. Growth Horm IGF Res, 42–43: p. 40–51
Gesing A et al (2011) Expression of key regulators of mitochondrial biogenesis in growth hormone receptor knockout (GHRKO) mice is enhanced but is not further improved by other potential life-extending interventions. J Gerontol A Biol Sci Med Sci 66(10):1062–1076
pubmed: 21788651 doi: 10.1093/gerona/glr080
Hoffman JM et al (2020) Transcriptomic and metabolomic profiling of long-lived growth hormone releasing hormone knock-out mice: evidence for altered mitochondrial function and amino acid metabolism. Aging 12(4):3473–3485
pubmed: 32091406 pmcid: 7066919 doi: 10.18632/aging.102822
Ropka-Molik K et al (2014) Comprehensive analysis of the whole transcriptomes from two different pig breeds using RNA-Seq method. Anim Genet 45(5):674–684
pubmed: 24961663 doi: 10.1111/age.12184
Hinrichs A et al (2021) Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation 28(2):e12664
pubmed: 33241624 doi: 10.1111/xen.12664
Griffith BP et al (2022) Genetically modified porcine-to-human Cardiac Xenotransplantation. N Engl J Med 387(1):35–44
pubmed: 35731912 pmcid: 10361070 doi: 10.1056/NEJMoa2201422

Auteurs

Jonathan A Young (JA)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Arne Hinrichs (A)

Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany.
Center for Innovative Medical Models (CiMM), Department of Veterinary Sciences, LMU Munich, Oberschleißheim, Germany.

Stephen Bell (S)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Delaney K Geitgey (DK)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.

Diana Hume-Rivera (D)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.

Addison Bounds (A)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.

Maggie Soneson (M)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.

Zvi Laron (Z)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva, Israel.

Danielle Yaron-Shaminsky (D)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva, Israel.

Eckhard Wolf (E)

Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany.
Center for Innovative Medical Models (CiMM), Department of Veterinary Sciences, LMU Munich, Oberschleißheim, Germany.
Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany.
Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany.

Edward O List (EO)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

John J Kopchick (JJ)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA.
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Darlene E Berryman (DE)

Edison Biotechnology Institute, Ohio University, Athens, OH, USA. berrymad@ohio.edu.
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA. berrymad@ohio.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH